article thumbnail

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

DAIC

“We appreciate the American Medical Association’s decision to assign FFRCT a Category I CPT code, a decision backed by years of research that highlights the positive impact FFRCT can have on the diagnosis and eventually treatment of patients with coronary artery disease,” said John Farquhar , CEO of HeartFlow.

article thumbnail

The Top Trends of ACC.25

CardiacWire

Cardiac CTs Rise Its clear the cardiology industry is warming up to cardiac imaging as imaging OEMs released cheaper specialized cardiac CTs to meet growing demand as a result of encouraging reimbursement changes. Reimbursement is Key A common question asked at ACC.25 25 was How do I get reimbursed?

article thumbnail

Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)

DAIC

Cardiac PET Industry Coalition CPIC passionately advocates for and protects the reimbursement of Cardiac PET, ensuring equitable access to innovative and life-saving technologies for healthcare providers and patients. For more information: www.positron.com If you enjoy this content, please share it with a colleague

article thumbnail

PO-05-101 HRS SURVEY TO ASSESS DETERMINANTS OF ENGAGEMENT IN RESEARCH AFTER GRADUATION FROM EP FELLOWSHIP

HeartRhythm

Concerns have emerged about the declining academic research opportunities during EP fellowship training and its impact on career trajectories. Moreover, the increasing emphasis on clinical productivity for reimbursements may deter some from pursuing research.

article thumbnail

American College of Cardiology, ACC, Releases Guide to Remote Patient Management

DAIC

Challenges also exist in developing a strategy at the practice level for implementing an RPM program, including reimbursement options and device integration into the clinician workflow. Surveys have shown clinicians are looking to professional medical societies to provide guidance on the optimal use of direct-to-consumer devices.

article thumbnail

The potential of artificial intelligence to revolutionize health care delivery, research, and education in cardiac electrophysiology

HeartRhythm

The rapid pace of innovation in EP may be hindered by several challenges including the aging population with increasing morbidity, the availability of multiple costly therapies that, in many instances, confer minor incremental benefit, the limitations of healthcare reimbursement, the lack of response to therapies by some patients, and the complications (..)

article thumbnail

Us2.ai’s Echo Strain Validation

CardiacWire

An international research team used Us2.ai’s with HFpEF) That last part is notable from an echo AI adoption perspective, given that CMS recently approved an outpatient reimbursement code for AI-based HFpEF detection ($285 per use) It could also prove to be notable for Us2.ai, The post Us2.ai’s